Showing results (1141-1150 of 4,506) with videos related to

Sort By:
Pageof 451
Advances in Therapy|December 28, 2024
Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary DiseaseDavid Mannino, Stephen Weng, Guillaume Germain, et al.
Advances in Therapy|January 2, 2025
CKD-Associated Pruritus is Associated with Greater Use of Antidepressants and Anti-pruritus MedicationsJasmine Ion Titapiccolo, Luca Neri, Thilo Schaufler, et al.
Advances in Therapy|December 31, 2024
Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH DatabaseRakesh Luthra, Aarth Sheth
Advances in Therapy|December 2, 2024
Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney CareRicardo Correa-Rotter, Steven J Chadban, Laura Christen, et al.
Advances in Therapy|December 5, 2024
Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims DataCorinne Young, Lydia Y Lee, Kristi K DiRocco, et al.
Advances in Therapy|December 28, 2024
Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical PracticeStella S Daskalopoulou, Helena Papacostas-Quintanilla, Romualda Brzozowska-Villatte, et al.
Advances in Therapy|December 18, 2024
Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett SyndromeMona Darwish, Julie Passarell, Kelly Maxwell, et al.
Advances in Therapy|December 16, 2024
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung DiseaseKelly P McCarrier, Mariam Hassan, Dayton W Yuen, et al.
Advances in Therapy|December 16, 2024
Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United KingdomJennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, et al.
Advances in Therapy|December 23, 2024
Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in JapanYoshikazu Inoue, Takashi Ogura, Arata Azuma, et al.
Pageof 451